FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Glibenclamide 2.5mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (PI) (Dowelhurst Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Unichem Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Daonil 5mg tablets (PI) (Dowelhurst Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Approved Prescription Services) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (C P Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Viatris UK Healthcare Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Approved Prescription Services) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Arrow Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (PI) (Dowelhurst Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diabetamide 2.5mg tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (A A H Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Daonil 5mg tablets (PI) (Waymade Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Waymade Healthcare Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diabetamide 5mg tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Alpharma Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Unichem Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (C P Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Waymade Healthcare Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Alpharma Limited) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Daonil 5mg tablets (PI) (Waymade Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (C P Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 2.5mg tablets (Kent Pharma (UK) Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Euglucon 5mg tablets (Aventis Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Water_for injections 500ml bottles VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Evorel Sequi patches 8 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Kefzol 1g powder for solution for injection vials (Eli Lilly & Co Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Balmonds Natural Shampoo & Body Wash (Balmonds Skincare Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Balmonds Natural Shampoo & Body Wash (Balmonds Skincare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Kefzol 1g powder for solution for injection vials (Eli Lilly & Co Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Theramex HQ UK Ltd) 8 patch 4 patches + 4 patches VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefazolin 1g powder for solution for injection vials (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Lexon (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefazolin 1g powder for solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefazolin 1g powder for solution for injection vials (Kent Pharma (UK) Ltd) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Waymade Healthcare Plc) 8 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Balmonds Natural Shampoo & Body Wash 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Doncaster Pharmaceuticals Ltd) 8 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Pilsco Ltd) 8 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Theramex HQ UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefazolin 1g powder for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Mawdsley-Brooks & Company Ltd) 8 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Evorel Sequi patches (Lexon (UK) Ltd) 8 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mifepristone 200mg tablets and Misoprostol 200microgram vaginal tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Medabon Combipack tablets (Sun Pharmaceutical Industries Europe B.V.) 1 pack 1 x (1 tab + 4 vaginal tabs) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Medabon Combipack tablets (Sun Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mifepristone 200mg tablets and Misoprostol 200microgram vaginal tablets 1 pack VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atenolol 5mg/10ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Intraven glucose 5% / sodium chloride 0.9% solution for injection 1litre bags (Ivex Pharmaceuticals) 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 1litre Viaflex bags (Baxter Healthcare Ltd) 10 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Intraven glucose 5% / sodium chloride 0.9% solution for injection 1litre bags (Ivex Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Steriflex No.13 potassium chloride 0.15% (potassium 10mmol/500ml) / glucose 5% infusion 500ml bags (Fresenius Kabi Ltd) 20 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Steriflex No.3 glucose 5% / sodium chloride 0.9% solution for injection 1litre bags (Fresenius Kabi Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitocin 20mg powder and solvent for intravesical solution vials (Vygoris Ltd) 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 1litre bags (Baxter Healthcare Ltd) 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials (medac UK) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 1litre bags (Baxter Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials (medac UK) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 1litre bags 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucose 5% / Sodium chloride 0.9% solution for injection 1litre bags 10 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tenormin 5mg/10ml solution for injection ampoules (Atnahs Pharma UK Ltd) 10 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitocin 20mg powder and solvent for intravesical solution vials (Vygoris Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tenormin 5mg/10ml solution for injection ampoules (Atnahs Pharma UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Steriflex No.3 glucose 5% / sodium chloride 0.9% solution for injection 1litre bags (Fresenius Kabi Ltd) 1 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitocin 20mg powder and solvent for intravesical solution vials (Vygoris Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Steriflex No.3 glucose 5% / sodium chloride 0.9% solution for injection 1litre bags (Fresenius Kabi Ltd) 10 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atenolol 5mg/10ml solution for injection ampoules 10 ampoule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Lacrilube eye ointment preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fibrelief 3.5g granules sachets (Manx Healthcare Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fibrelief 3.5g granules sachets (Manx Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 7 of 86 Next End

This concept is not in any reference sets

Back to Start